|
 |
InfliximabThis page contains recent news articles, when available, and an overview of Infliximab but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Infliximab (when available) Used in the treatment of auto-immune disorders such as Crohn'€™s disease and rheumatoid arthritis. Infliximab binds to tumor necrosis factor alpha (TNFa) and inhibits binding of TNFa with its receptors. This reduces production of pro-inflammatory cytokines such as interleukins (IL) 1 and 6. This also limits leukocyte migration and expression of adhesion molecules by endothelial cells and leukocytes. Infliximab also limits the activation of neutrophil and eosinophil functional activity, reduces production of tissue degrading enzymes produced by synoviocytes and/or chondrocytes. Infliximab decreases synovitis and joint erosions in collagen-induced arthritis and allows eroded joints to heal. For treatment of Crohn's disease, psoriasis, rheumatoid arthitis and ankylosing spondylitis Mechanism Of Action: Infliximab neutralizes the biological activity of TNFa by binding with high affinity to the soluble and transmembrane forms of TNFa and inhibits binding of TNFa with its receptors. Infliximab does not neutralize TNFb (lymphotoxin a), a related cytokine that utilizes the same receptors as TNFa News Articles on Infliximab Turmeric (Curcumin) for Inflammatory Conditions - 05 Jan 2010 Inhibition of the production of TNF-alpha, which is the cytokine targeted by etanercept (Enbrel), infliximab (Remicade) and newer drugs; and 3. ... EmpowHer (blog) 澳大利亚è¦å‘ŠTNF抑制剂å?¯èƒ½å¼•å?‘è?¯æº?性红斑狼疮 - 05 Jan 2010 TNF抑制剂是被批准用于治疗风湿病ã€?银屑病关节炎ã€?强直性脊柱炎和克罗æ?©æ°?病的一ç§?有效的å…?疫抑制剂，æ¤ç±»è?¯ç‰©æœ‰è‹±å¤«åˆ©è¥¿å?•æŠ—（infliximab）ã€?阿达木å?• ... 中国医药网 A New Ulcerative Colitis Biologic With a Novel Mechanism of Action Would Earn ... - Jan 4, 2010 The new report entitled Ulcerative Colitis: Gastroenterologists Identify Emerging Drugs That Will Challenge the Benchmark Therapy Infliximab for Moderate to ... PR Newswire (press release) Cost-utility analysis of infliximab and adalimumab for refractory ulcerative ... - Dec 12, 2009 ObjectiveTo evaluate cost-utility of infliximab and adalimumab for treatment of moderate-to-severe UC refractory to conventional therapies in Canada. ... 7thSpace Interactive (press release) Uveitis a complex disease, but treatable in most cases - Jan 4, 2010 ...something as simple as once-a-week methotrexate or as complex as episodic intravenous cyclophosphamide or once-monthly Remicade (infliximab, Centocor). ... OSN SuperSite Patients with a crippling gut condition 'could be made ill under plans to ... - Dec 11, 2009 Michael Addelman, from Manchester, whose seven-year-old son Jake currently takes one of the drugs involved, Infliximab, said that to remove his son's ... Telegraph.co.uk Health tip: - Dec 19, 2009 More aggressive Crohn's may require treatment with steroids, immunosuppresants, or a medication called infliximab (brand name: Remicade). Tehran Times Biologics Transform RA Outlook - Dec 31, 2009 These were infliximab (Remicade), a monoclonal antibody against TNF, and etanercept (Enbrel), a soluble version of a TNF receptor protein, both of which sop ... MedPage Today Psoriasis can affect the joints as well as the skin - Dec 27, 2009 Two examples are etanercept (Enbrel) and infliximab (Remicade). Dear Dr. Donohue: All of a sudden, my left hip became painful. ... Herald & Review New and Upcoming Biologic Agents for Rheumatoid Arthritis - Dec 29, 2009 The first agents developed include TNF-æ±? blockers, infliximab (Remicade, Centocor), etanercept (Enbrel, Amgen), and adalimumab (Humira, Abbott) and the ... Ortho SuperSite TNF Blockers: Miracle Drugs or Minefields? - Dec 17, 2009 There are four currently on the market, all with names that end in the letters “mabâ€?: infliximab, adalimumab, certolizumab, and golimumab. ... EmpowHer (blog) Crohn's & Colitis Foundation Presents National Science Awards to Clinical and ... - Dec 17, 2009 His research efforts helped to establish key treatments for treating IBD such as 6-MP, azathioprine, and infliximab. In addition, his dedication and strong ... PR Web (press release) Adalimumab е ефективна Ñ?паÑ?ителна терапиÑ? при млади пациенти Ñ? болеÑ?Ñ‚ на Крон ... - Jan 4, 2010 Adalimumab е ефективен Ñ?паÑ?ителен медикамент при деца и юноши Ñ? болеÑ?Ñ‚ на Крон, при които Ñ?е налага Ñ?пиране на терапиÑ?та Ñ? infliximab. ... DoctorBG.com Psoriasi: i sintomi iniziali fondamentali per il trattamento terapeutico - Dec 11, 2009 Detto ciò gli specialisti ammettono invece importanza in fatto di percezione dei risultati terapeutici dei pazienti trattati con Infliximab, l'anticorpo ... NanoPress (Blog) Infliximab Bests DMARDs in Controlling Radiological Progression in Patients ... - Oct 21, 2009 During year 2, significant progression was seen only in the group treated with conventional therapy, and not in the group treated with infliximab. ... DG News ACG: Study Marks 10-Year History of Anti-TNF Therapy for Crohn's - Oct 30, 2009 SAN DIEGO -- About 20% of the 500 patients who received infliximab (Remicade) for Crohn's disease between ... MedPage Today ACR: Anti-TNF Therapy Better in Refractory RA - Oct 23, 2009 Another 128 patients underwent treatment with infliximab 3 mg/kg in addition to methotrexate. Radiographs taken at baseline and at 12 and 24 months were ... MedPage Today Centocor, Inc. - SWOT Analysis - Oct 22, 2009 The company markets blockbuster drug, Remicade (infliximab) in the US for a number of indications including rheumatoid arthritis and adult Crohn's disease. ... PRMinds (press release) TB risk varies between anti-TNFs - Nov 1, 2009 Infliximab and adalimumab are associated with a three- to four-fold higher rate of tuberculosis compared to etanercept, data from the British Society for ... Rheumatology Update New data from CIMZIA WELCOME trial to be presented at the ACG meeting - Oct 28, 2009 These exploratory data from the WELCOME trial, which studied patients who had been on the anti-TNF therapy infliximab, but failed or developed a ... News-Medical.net No Increased Cancer Risk with Anti-TNF Therapy in RA - Oct 29, 2009 There also may have been detection bias, in that patients receiving infliximab -- which is given as an infusion rather than subcutaneously -- would have ... MedPage Today Band-Aid Won't Stop Generic Bleeding at Johnson & Johnson - Nov 11, 2009 Of greatest concern, the slowing growth of its flagship drug, the tumor necrosis factor-α (TNF -α) blocker Remicade (infliximab), which contributes almost ... BNET Decision Resources: Biosimilars may cause biotech companies to lose more than ... - Nov 11, 2009 TNF-alpha inhibitors include Enbrel (etanercept), by Amgen and Eli Lilly & Co., Abbott's Humira (adalimumab) and Remicade (infliximab), ... Drug Store News (blog) ACR: Rheumatoid Arthritis Biologics Increase Risk of Skin Cancer - Oct 18, 2009 However, the use of infliximab was associated with an almost 3 fold increase in risk of NMSC in this group (Fully adjusted HR 2.9, 95% CI 1.4 to 6.1). ... MedPage Today Treatment of Polymyalgia Rheumatica A Systematic Review - Nov 9, 2009 Infliximab was ineffective as initial cotreatment. Conclusions The scarcity of randomized trials and the high level of heterogeneity of studies on PMR ... Archives of Internal Medicine The revolution in battling child arthritis - Oct 21, 2009 It suggested positive effects from a combination of methotrexate and the TNF infliximab - sold as Remicade by Horsham-based Centocor Ortho Biotech Inc. "A ... Philadelphia Inquirer High Court rejects B-MS bid for NICE legal challenge - Nov 10, 2009 Wyeth's Enbrel (etanercept) and Schering-Plough's Remicade (infliximab) for the treatment of RA, as well as Roche's MabThera/Rituxan (rituximab) as an ... Pharma Times Centocor Says Long-Term Data Shows Improvements In Simponi-treated Rheumatoid ... - Oct 19, 2009 Findings from the study demonstrated that patients with RA previously treated with adalimumab, etanercept or infliximab responded to, and maintained ... RTT News New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis - Oct 19, 2009 ...that patients with RA previously treated with adalimumab, etanercept or infliximab responded to, and maintained response to, SIMPONI through one year. ... Reuters Polyarticular JIA: The Elusive Quest for Disease Remission - Nov 2, 2009 Seventy-two percent of patients were treated with methotrexate and 11.5% with an anti-tumor necrosis factor (TNF) medication such as etanercept, infliximab, ... AAP Grand Rounds (registration) ACR70-disease activity score remission achievement from switches between all ... - Nov 3, 2009 Results: 9 articles were included: switch from etanercept and/or infliximab and/or to adalimumab is effective with an ACR70 response from 5% to 33%. ... 7thSpace Interactive (press release) Cancer patients face 'treatment lottery' - Nov 3, 2009 ..."Infliximab is licensed to treat Crohn's disease, ulcerative colitis and ankylosing spondylitis, among other conditions, but it is also prescribed off label ... ePolitix Centocor reports positive data from two Phase III arthritis trials - Oct 21, 2009 Findings from the Go-After study demonstrated that patients with RA previously treated with adalimumab, etanercept or infliximab responded to, ... Trading Markets (press release) Lords debate Health: Medicines - Oct 30, 2009 Infliximab is licensed to treat Crohn's disease, ulcerative colitis and ankylosing spondylitis, among other conditions, but it is also prescribed off label ... DeHavilland (press release) (subscription) Merck & Co earnings climb as Januvia and Isentress impress - Oct 23, 2009 The anti-inflammatory Remicade (infliximab), the Johnson & Johnson drug which SP sells outside the USA, grew 8% to $608 million, while sales of the ... Pharma Times Medicatie voor reumapatiënt kan efficiënter ingezet - Nov 12, 2009 Het gebruik van het geneesmiddel infliximab voor mensen met reumatoïde artritis kan efficiënter. Dat blijkt uit onderzoek van apotheker Bart van den Bemt ... Nieuws.nl 셀트리온, 대규모 ë°”ì?´ì˜¤ì‹œë°€ëŸ¬ ì œí’ˆ 수주 - Oct 19, 2009 ...셀트리온ì?€ 19ì?¼ 장 마ê°?후 공시ì—?ì„œ 최대주주ì?¸ 셀트리온헬스케어와 ë°”ì?´ì˜¤ì‹œë°€ëŸ¬ í•ì²´ì?˜ì•½í’ˆ(Trastuzumab,Infliximab) íŒ?매 계약ì?„ ì²´ê²°í–ˆë‹¤ê³ ë°?혔다. ... 파이낸셜뉴스 Nova terapêutica biológica consegue melhorar lesões cutâneas da psorÃase - Nov 10, 2009 Uma nova terapêutica biológica (infliximab) promete revolucionar o paradigma terapêutico da psorÃase. O fármaco comprovou melhorar em, pelo menos, ... RCM Pharma La psoriasis afecta la calidad de vida de los seres humanos - Oct 30, 2009 La especialista expuso que la terapia biológica intravenosa como infliximab ha tenido resultados satisfactorios en más de un millón de personas tratadas en ... Mnoticias PRESENTAN MÉDICOS MEXICANOS LIBRO SOBRE LA ESPONDILITIS ANQUILOSANTE - Oct 24, 2009 Esto es posible con terapias como infliximab, es el único tratamiento biológico que cuenta con más de un millón de personas tratadas en el mundoâ€?, ... Top Management Mexico 'Op maat' behandeling van reuma patiënten voorkomt verdere schade aan gewrichten. - Oct 20, 2009 Het matrix model helpt voorspellen wie een hoog risico heeft en dus beter af zal zijn met een behandeling met prednison of infliximab.â€?. ... Medical facts Reumamedicijn heeft ook gunstig effect op aderverkalking en botontkalking - Oct 22, 2009 De introductie van biologicals als infliximab en etanercept betekende begin jaren negentig een grote omslag in de behandeling van reumatoïde artritis, ... Nieuwsbank (persbericht) (abonnement) ê±´ì„ Â·í?¬ë¡ 병 시장 '휴미ë?¼' 주ë?„ - Nov 10, 2009 ...한편, í?¬ë¡ 병 시장ì—?ì„ í–¥í›„ 10ë…„ê°„ 휴미ë?¼ì™€ 'ë ˆë¯¸ì¼€ì?´ë“œ'(Remicade, infliximab)ì—? í•„ì ?하는 ê²½ìŸ? ì‹ ì•½ì?´ 나오지 ì•Šì?„ 것으로 ë³´ì—¬ ë‘? ì¹˜ë£Œì œì?˜ 지배는 계ì†?ë? ì „ë§? ... 디지틀보사 Fármaco pode reduzir para metade cirurgias em doentes com colite ulcerosa - Nov 4, 2009 ...publicada na revista Gastroenterology, sugere que o tratamento da colite ulcerosa moderada a grave com Remicade® (infliximab) possa reduzir para metade ... RCM Pharma 류마티스 치료 '엔브ë ?ì—?ì„œ ì•…í…œë?¼ë¡œ' - Nov 4, 2009 ...디시즌리소스가 미êµì—?ì„œ ì?˜ì‚¬ë“¤ì?„ 대ìƒ?으로 조사한 ê²°ê³¼ì—? ì?˜í•˜ë©´ 엔브ë ?, '휴미ë?¼'(Humira, adalimumab), 'ë ˆë¯¸ì¼€ì?´ë“œ'(Remicade, infliximab) 등 기존ì?˜ TNF-알파 ... 디지틀보사 Tratamento para a artrite reumatóide não aumenta risco de cancro - Nov 6, 2009 ...iniciado a terapia com bloqueadores do TNF-alfa, nomeadamente com o infliximab, adalimumab ou o etanercept, entre Janeiro de 1999 e Julho de 2006. ... RCM Pharma Geneesmiddelen en bijwerkingen; TNF-a-remmers en tuberculose - Nov 6, 2009 Van het middel infliximab (merknaam Remicade) is bekend dat het niet zelden latente tuberculose reactiveert, soms met fatale afloop. ... Medisch Dossier Inflamación intestinal puede provocar la muerte - Oct 27, 2009 ..."La terapia biológica con infliximab, un anticuerpo monoclonal que bloquea el Factor de Necrosis Tumoral alfa (TNF), mismo que está implicado en los ... TabascoHoy.com 有些IBDè—¥ç‰©æœƒå¢žåŠ çš®è†šç™Œé¢¨éšª - Nov 4, 2009 ...生物製劑藥物，包括infliximab(商å“?å??Remicade)與其他。 * 長期使用，定義為使用1年以上，與皮膚癌風險有強烈關è?¯ã€‚æœ?用巰基嘌呤藥物超é?Ž1å¹´è€…ï¼Œçš®è†šç™Œé¢¨éšªå¢žåŠ 4å€?ï¼› ... 臺灣新浪網 Besser für den Bauch - Oct 25, 2009 Seit einiger Zeit werden erfolgreich Antikörper gegen TNF-alpha eingesetzt, etwa Infliximab (vermarktet als „Remicade“). Die Antikörper heften sich an ... Tagesspiegel Infliximab-Based Treatment Effective for Crohn's Patients - Oct 8, 2008 THURSDAY, Oct. 9 (HealthDay News) -- Infliximab (Remicade) alone or in combination with azathioprine is more effective in treating Crohn's disease than ... Forbes Infliximab, a drug initially aimed at rheumatoid arthritis, may be... - Oct 21, 2005 Even in its mildest form, psoriasis can drive sufferers to distraction. The condition leaves the skin covered in red, itchy scales, and giving in to the ... Times Online Ulcerative Colitis Medications - Ulcerative Colitis Health Information... - Feb 20, 2008 In 2006, infliximab was approved to help maintain as well as induce remission. Doctors do not recommend infliximab as a first-line drug for ulcerative ... New York Times Alternatives to methotrexate for infliximab combination therapy in … - Jun 1, 2006 Perdriger A et al. (2006) Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice. ... Nature.com Infliximab treatment strategy: dose titration based on response in... - May 9, 2007 Flendrie M et al. (2007) Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns. Rheumatology 46: 146–149 PubMed ... Nature.com Efficacy and safety of infliximab for the treatment of psoriatic... - Mar 13, 2006 Antoni C et al. (2005) Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 64: 1150–1157 PubMed ... Nature.com Clinical and radiographic response to a local infliximab injection in... - Sep 9, 2008 Background A 49-year-old man presented to a rheumatology clinic with a 2-month history of low back pain. The pain seemed to be inflammatory in origin, ... Nature.com Should infliximab be used to help maintain glucocorticosteroid... - Jun 26, 2007 Hoffman GS et al. (2007) Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. ... Nature.com Ulcerative colitis - Oct 4, 2005 Infliximab (Remicade). This drug received Food and Drug Administration approval ... Infliximab finds TNF in your bloodstream and removes it before it causes ... cnn.com Infliximab for rheumatoid arthritis - Aug 18, 2008 Infliximab reduces the effects of tumor necrosis factor (TNF). TNF is a protein that attaches to the joint surface and causes inflammation and joint damage. ... WebMD … -Alpha Binding Capacity and Anti-Infliximab Antibodies Measured by ... - Jan 28, 2007 To investigate if the combined assessment of anti-infliximab antibodies (Ab) and ... At 8 wk after last infliximab infusion, TNF-alpha-BC was significantly ... Nature.com The Effects of Infliximab Therapy on Health-Related Quality of Life... - Jun 30, 2006 Correspondence: Brian G Feagan, MD, The University of Western Ontario, The Robarts Research Institute, 100 Perth Drive, London, Ontario, Canada N6A 5K8. ... Nature.com How do the efficacy and safety of abatacept and infliximab compare in... - Nov 19, 2008 Factors influencing the choice of biologic therapy for a given individual include the need for rapid response, as observed with infliximab treatment in this ... Nature.com Infliximab in psoriasis: Highly effective for both skin and nails - Oct 14, 2005 G ¿ ttingen, Germany - Results from a phase 3 trial of infliximab (Remicade, Centocor & Schering-Pough) in moderate to severe psoriasis show that ... Medscape Pharmacokinetics of Murine p75-Fc Fusion Protein and MP6-XT22 Anti- … - Sep 4, 2006 For example, infliximab is a murine mAb that is a very weak inhibitor of murine ... To overcome these immunologic limitations, analogs of infliximab and ... Nature.com GAIN for Loss: Adalimumab for Infliximab-Refractory Crohn Disease - Jun 19, 2007 The much-anticipated revolution that anti–tumor necrosis factor- (anti–TNF-) antibodies brought to conventional treatment for Crohn disease nearly a decade ... Annals of Internal Medicine Maintenance Infliximab Treatment Is Associated with Improved Bone … - Feb 9, 2005 Diminished bone mineral density (BMD) is a recognized complication of Crohn's disease (CD). The mechanisms underlying bone loss are unclear but may include ... Nature.com Infliximab therapy for patients with ankylosing spondylitis: on... - Mar 25, 2008 Breban M et al. (2008) Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic ... Nature.com Infliximab-induced disseminated histoplasmosis in a patient with... - Nov 29, 2007 Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME ... Nature.com Infliximab Induces Remission of Ulcerative Colitis - Dec 7, 2005 NEW YORK DEC 07, 2005 (Reuters Health) - Treatment of moderate-to-severe active ulcerative colitis, a severe inflammatory disease of the colon, ... Cancerpage.com Remicade: infliximab.(New indications)(Centocor Inc.) - Nov 1, 2006 Monoclonal antibody approved for the treatment of chronic plaque psoriasis Infliximab acts through the inhibition of tumor necrosis factor (TNF)-alpha, ... Free with registration - Formulary - AccessMyLibrary.com Adalimumab, etanercept and infliximab are equally effective treatments... - Jun 20, 2008 As adalimumab, etanercept and infliximab are equally effective in the treatment of patients with psoriatic arthritis, all three anti-TNF agents should be ... Nature.com Infliximab Benefits Continue for 2 Years in AS - Jun 15, 2007 This activity is not sanctioned by, nor a part of, the European League Against Rheumatism. June 18, 2007 (Barcelona) — Patients with ankylosing spondylitis ... Medscape Nonresponse to tumor necrosis factor antagonists—is there any point... - Nov 3, 2005 Although infliximab binds both monomeric and trimeric (bioactive) TNF, ... The majority of 'switch' studies have been of infliximab and etanercept, ... Nature.com Infliximab receives expanded psoriatic arthritis indication.(Rheumatol... - Oct 1, 2006 The approved psoriatic arthritis indication for infliximab has been expanded to reflect data showing that the immune modulator has a positive impact on ... Free with registration - Internal Medicine News - AccessMyLibrary.com Infliximab May Not Benefit Patients With COPD - May 1, 2007 May 1, 2007 -- Infliximab was not beneficial in patients with moderate to severe chronic obstructive pulmonary disease after 6 months of treatment, ... Medscape Impact of treatment with infliximab on anticyclic citrullinated... - Nov 1, 2006 Objective: To investigate the impact of infliximab treatment on anticyclic citrullinated peptide (anti-CCP) antibody and rheumatoid factor (RF) levels in ... Free with registration - Southern Medical Journal - AccessMyLibrary.com Aggressive Therapy for Crohn's Disease Produces Better Outcomes - Feb 22, 2008 Sixty-seven patients assigned to combined immunosuppression received three infusions of Remicade (infliximab) with Imuran (azathioprine) at the start, ... Washington Post DDW: Remicade (infliximab) Improves Symptoms in Refractory Ulcerative... - May 18, 2005 By Jerry Ingram,. CHICAGO, May 18-Remicade (infliximab) appears to improve symptoms for ulcerative colitis in patients who are refractory to conventional ... MedPage Today Remicade® (infliximab) Receives Scottish Medicines Consortium Ruling ... - May 10, 2007 The Scottish Medicines Consortium (SMC) today announced that Remicade® (infliximab) is approved for restricted use within the NHS Scotland for the treatment ... Medical News Today - Medical News Today (press release) … Tri-State's News and Weather Leader-Infliximab Helps Curb Worsening... - Oct 2, 2006 MONDAY, Oct. 2 (HealthDay News) -- The drug infliximab significantly reduced disease exacerbations in people with moderate asthma, new UK research finds. ... WFIE-TV ACG: TREAT Registry Finds No Extra Risk with Infliximab for Crohn's - Oct 9, 2008 By Ed Susman, Contributing Writer, MedPage Today. ORLANDO, Oct. 9 -- Infliximab (Remicade) for Crohn's disease is no riskier than the use of other ... MedPage Today Treatment of Sarcoidosis With Infliximab* - Mar 30, 2005 Background/objectives: Many patients with sarcoidosis are unable to tolerate corticosteroids or alternative therapeutic agents due to side effects or have ... RedOrbit Infliximab With Low-Dose Methotrexate for Prevention of Postsurgical ... - Sep 10, 2007 Postsurgical recurrence of Crohn disease is a very frequent event, and none of the drugs used for the purpose has really shown a clear-cut efficacy. ... Archives of Internal Medicine Infliximab-Intolerant Patients With Crohn's Disease Respond to … - Oct 24, 2006 By Paula Moyer. LAS VEGAS, NV -- October 24, 2006 -- Patients with moderate-to-severe Crohn's disease who have not responded to infliximab (Remicade) or ... DG News Infliximab (Remicade) Treated Plaque Psoriasis Patients Show … - Feb 4, 2008 By Bruce Sylvester. SAN ANTONIO, TX -- February 4, 2008 -- Researchers report that patients with moderate to severe plaque psoriasis receiving infliximab ... DG News Switching tumor necrosis factor inhibitors: an opinion - Jul 19, 2005 Monoclonal antibodies, such as infliximab and adalimumab, ... 1 Unlike infliximab and adalimumab, etanercept is capable of binding lymphotoxin and has not ... Nature.com Infliximab Injection Side Effects from Consumer Reports Health. - Jan 4, 2007 Infliximab may decrease your ability to fight infection and increase the risk that you will get a ... Full Alert. Infliximab may decrease your ability to ... consumerreports.org Sustained efficacy and safety of infliximab in psoriasis: a retrospect... - Mar 1, 2006 Background: Infliximab inhibits T-cell activation by binding tumor necrosis factor-[alpha] (TNF-[alpha]). This medication is widely used in the US for ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com Abatacept And Infliximab Improve Clinical Response Over Time In … - Jun 16, 2008 New data presented at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France, show that over half of rheumatoid ... Medical News Today - Medical News Today (press release) ACG: Infliximab (Remicade) Reduces Colectomy Risk in Ulcerative... - Oct 17, 2007 By Charles Bankhead, Staff Writer, MedPage Today. PHILADELPHIA, Oct. 17 -- Ulcerative colitis patients had up to a 50% reduction in colectomy risk at one ... MedPage Today Data Supports Launch Of Remicade(R) (infliximab) For The Treatment Of... - Oct 11, 2005 Remicade(R) (infliximab) is launched today in the UK for the treatment of moderate to severe plaque psoriasis. This new indication, supported by the ... Medical News Today - Medical News Today (press release) Eye - Adalimumab for sight-threatening uveitis in Behcet's disease - Apr 7, 2006 4 Infliximab requires day case hospital admission for intravenous infusions at ... Infliximab iv infusions were started at 5 mg/kg given at 0, 2, 6, 14, 18, ... Nature.com … Disease Patients Achieve Remission With Certolizumab After Inflixim... - May 21, 2008 Six weeks after switching from infliximab, 68% of patients treated with certolizumab pegol had achieved a reduction of 70 points on the CDAI. ... DG News NHS in England to deny arthritis treatment - Nov 13, 2007 ...have recommended that the drug, infliximab, which costs £15000 a year and is given through a drip in hospital, is not "cost-effective". ... Telegraph.co.uk Restarting infliximab in AS - Apr 7, 2005 Herne, Germany - While continuous treatment with infliximab (Remicade, Centocor) is necessary for many patients with ankylosing spondylitis (AS), ... Medscape Adalimumab can suppress Crohn's after infliximab fails.(Gastroenterolo... - Dec 1, 2006 BERLIN -- Treatment with adalimumab led to significantly more remissions than did placebo in patients with moderately to severely active Crohn's disease who ... Free with registration - Internal Medicine News - AccessMyLibrary.com Long-Term Therapy With Infliximab Proves Effective and Safe in … - Oct 21, 2008 By Judith Moser, MD. VIENNA, Austria -- October 21, 2008 -- Treatment with infliximab for more than 1 year results in prolonged response or remission, ... DG News Infliximab approved for psoriatic arthritis in US - May 18, 2005 Malvern, PA - The US FDA has approved the TNF blocker infliximab (Remicade, Centocor) "to reduce the signs and symptoms of active arthritis in patients with ... Medscape Initial Better Than Delayed Treatment With Infliximab Plus Methotrexat... - Jun 15, 2007 By Chris Berrie. BARCELONA, SPAIN -- June 15, 2007 -- For patients with early rheumatoid arthritis (RA), initial treatment with infliximab is more effective ... DG News Infliximab (Systemic). - Feb 1, 2006 Infliximab (in-FLIX-i-mab) is a monoclonal antibody. It is used to treat Crohn's disease in patients who have not been helped by other medicines and also in ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Infliximab Induces High Clinical Response for Moderate to Severe UC - May 17, 2005 May 17, 2005 (Chicago) — Infliximab can significantly improve symptoms in patients with moderate to severe ulcerative colitis (UC), according to findings ... Medscape INFLIXIMAB (Injection route, Intravenous route) - in-FLIX-i-mab.(Drug... - May 1, 2007 ...* Patients treated with infliximab are at increased risk for infections, including progression to serious infections leading to hospitalization or death. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Use of Infliximab Does Not Reduce Rate of Fistulas in Patients With … - Oct 17, 2008 By Roberta Friedman, PhD. SAN FRANCISCO -- October 17, 2008 -- Use of the anti-tumour necrosis factor-alpha inhibitor infliximab in Crohn's disease has not ... DG News … gets FDA approval for expanded marketing of REMICADE (Infliximab) - Aug 21, 2006 Centocor, Inc. announced on August 14 that the FDA has expanded marketing approval for REMICADE® (infliximab) for the treatment of psoriatic arthritis. ... HealthCentral.com First Study of Infliximab Treatment in Patients With Chronic Obstructi... - Aug 25, 2005 Rationale: Tumor necrosis factor-α is believed to be important in the induction and maintenance of airway inflammation in chronic obstructive pulmonary ... RedOrbit Infliximab More Effective in Treating Crohn's Disease Vs Azathioprine... - Oct 13, 2008 October 13, 2008 (Orlando) — In a large phase 3b trial that several clinicians at the American College of Gastroenterology (ACG) Annual Scientific Meeting ... Medscape The Safety of Extended Use of Infliximab for Crohn's Disease:... - May 22, 2007 By Bruce Sylvester. WASHINGTON, DC -- May 22, 2007 -- Greater infliximab (Remicade ®) exposure is not associated with an increased risk of mortality or ... DG News Withdrawing Infliximab in a Patient Receiving Methotrexate - Mar 14, 2006 When Is it Safe to Withdraw Infliximab in a Patient Receiving Combination Therapy With Methotrexate? I have a 25-year-old female patient with juvenile ... Medscape NICE Issues Guidance on the Use of Infliximab for Acute Exacerbations... - Dec 17, 2008 LONDON -- December 17, 2008 -- The National Institute for Health and Clinical Excellence (NICE) has published guidance on the use of infliximab for acute ... DG News New Analyses Support Infliximab Use for Severe Psoriasis, Show … - Feb 5, 2007 By Bruce Sylvester. WASHINGTON, DC -- February 5, 2007 -- A retrospective analysis of data from 3 major clinical trials shows that more than three quarters ... DG News Scheduled infliximab therapy offers long-term IBD benefits - Nov 5, 2007 By Liam Davenport. MedWire News: A scheduled infliximab strategy is an effective method for maintaining long-term clinical remission in patients with ... Medwire (subscription) NICE Denies Infliximab For The Treatment Of Ankylosing Spondylitis, UK - May 30, 2008 Schering-Plough is extremely disappointed with the outcome of the National Institute for Health and Clinical Excellence (NICE) appeal panel with regards to ... Medical News Today - Medical News Today (press release) UK body approves pemextred and infliximab - Jan 25, 2008 The UK's cost-effectiveness body, the National Institute for Health and Clinical Excellence (NICE), has approved use of pemextred (Alimta®) and infliximab ... Pharmacy Europe Infliximab Counteracts Higher BMI in Achieving Remission in Early … - Nov 13, 2007 By Bruce Sylvester. BOSTON, MA -- November 13, 2007 -- Body mass index (BMI) has a strong effect on whether early rheumatoid arthritis (RA) patients achieve ... DG News Infliximab (Remicade) Linked to Atherosclerosis - Jun 11, 2007 Over the past few years, studies have shown that people with rheumatoid arthritis and other rheumatic diseases have a higher risk of cardiovascular disease ... HealthCentral.com Infliximab (Remicade[R]) to treat dermatomyositis and polymyositis.( … - Jul 1, 2005 This study is currently recruiting patients. Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com … with ankylosing spondylitis during infliximab therapy.(CASE... - Aug 1, 2007 Although therapy with infliximab is generally well-tolerated, ... Due to a poor response to conventional treatment, infliximab (Remicade[R]) 5 mg/kg at 0, ... $4.95 - Journal of Drugs in Dermatology - ECNext Infliximab: Continuous or as Needed? - Mar 1, 2007 A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com Infliximab Significantly Improves and Sustains Productivity in... - Feb 6, 2007 By Bruce Sylvester. WASHINGTON, DC -- February 6, 2007 -- Patients with moderate to severe plaque psoriasis who were treated with infliximab (Remicade) ... DG News FDA Approves Remicade (infliximab) as First and Only Biologic... - May 22, 2006 HORSHAM, PA -- May 22, 2006 -- Centocor, Inc. announced that the US Food and Drug Administration (FDA) has approved Remicade(R) (infliximab) for reducing ... DG News Infliximab associated new-onset psoriasis.(CASE REPORTS) - Feb 1, 2006 Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com Is treatment with tumor necrosis factor inhibitors safe in pregnant... - Jun 8, 2007 Treatment with TNF inhibitors such as adalimumab, etanercept and infliximab is often prescribed for patients with rheumatoid arthritis (RA); however, ... Nature.com … carinii jiroveci pneumonia following infliximab infusion for Crohn... - Mar 1, 2007 ...(1,2) PCP following infliximab therapy for Crohn disease, although still uncommon, ... Later on, the patient did receive another dose of infliximab as an ... Free with registration - Southern Medical Journal - AccessMyLibrary.com Infliximab (Remicade[R]) to treat dermatomyositis and polymyositis.( … - Mar 1, 2005 This study is currently recruiting patients. Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com Dose Escalation of Infliximab Is Helpful in Active Rheumatoid... - Jun 7, 2007 June 7, 2007 — In patients with active rheumatoid arthritis (RA), dose escalation of infliximab is associated with more than 20% improvement in tender and ... Medscape Infliximab Fails Test in Two Rheumatologic Diseases - Apr 30, 2007 By Michael Smith, Senior Staff Writer, MedPage Today. CLEVELAND, April 30 -- Infliximab (Remicade) showed no efficacy against two related rheumatic diseases ... MedPage Today … (Abatacept) or REMICADE(R)(Infliximab) Demonstrated Superior... - Nov 14, 2006 WASHINGTON, Nov. 14 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company today announced results from a study providing further evidence of the efficacy, ... RedOrbit How to take Infliximab Injection from Consumer Reports Health. - Jan 4, 2007 Infliximab may decrease your ability to fight infection and increase the risk that you will get a ... Full Alert. Pending revision, the material in this ... consumerreports.org … of Spontaneous Cases of Tuberculosis Associated with Infliximab - Nov 20, 2007 In the subset of 67 cases with documented initiation of infliximab therapy after ... This series reviewed 130 cases of infliximab-associated tuberculosis ... Annals of Internal Medicine Infliximab Does Not Improve Antineutrophil Cytoplasm Antibody … - Nov 6, 2007 By Bryan DeBusk, PhD. SAN FRANCISCO, CA -- November 6, 2007 -- Despite widespread use of infliximab as an additional immunosuppressive agent in patients ... DG News Learn about Infliximab Injection from Consumer Reports Health. - Jan 4, 2007 Infliximab may decrease your ability to fight infection and increase the risk that you will get a ... Full Alert. Pending revision, the material in this ... consumerreports.org School's no place for knife - Jun 10, 2007 IT is great to see Matthew Cass, the schoolboy Victorians took into their hearts, firing on all cylinders after being treated with Infliximab for Crohn's ... NEWS.com.au Psoriatic arthritis indication backed for infliximab.(News)(Brief... - Jan 1, 2005 The US Food and Drug Administration has accepted Centocor Inc.'s application to approve infliximab (Remicade) for the treatment of psoriatic arthritis. ... Pay-Per-View - Skin & Allergy News - Factiva, from Dow Jones … ocular sarcoidosis respond to infliximab.(Dermatologic Therapy) |... - Sep 1, 2006 Two patients with ocular sarcoidosis respond to infliximab. ... AMSTERDAM -- Treatment with infliximab successfully controlled refractory ocular ... Pay-Per-View - Skin & Allergy News - HighBeam Research Infliximab Maintenance Therapy Induces and Maintains Endoscopic … - Oct 19, 2005 By Chris Berrie. COPENHAGEN, DENMARK -- October 19, 2005 -- Systematic maintenance therapy with infliximab, a monoclonal antibody against tumour necrosis ... DG News Infliximab effective for refractory sarcoidosis.(Clinical Rounds) - Jan 1, 2007 SALT LAKE CITY -- Infliximab is a highly effective and safe therapy for patients with multisystem sarcoidosis refractory to conventional immunomodulatory ... Free with registration - Skin & Allergy News - AccessMyLibrary.com Adding Infliximab to Combination DMARD Treatment for Early … - Jun 14, 2008 By Bruce Sylvester. PARIS -- June 14, 2008 -- Adding infliximab to an effective combination disease modifying antirheumatic drug (DMARD) regimen for the ... DG News Infliximab effective for active ulcerative colitis: in two phase III... - Oct 15, 2005 CHICAGO -- Active ulcerative colitis responds to the drug infliximab, according to results of two multicenter phase III trials reported at the annual ... Free with registration - Family Practice News - AccessMyLibrary.com Early treatment with Infliximab and Methotrex shows benefit for … - Jun 17, 2007 Early treatment with a combination of methotrexate and infliximab may be effective as remission induction therapy and alter the course of early rheumatoid ... News-Medical.net Taking Infliximab Injection from Consumer Reports Health. - Jan 4, 2007 Infliximab may decrease your ability to fight infection and increase the risk that you will get a ... Full Alert. Pending revision, the material in this ... consumerreports.org A woman with rheumatoid arthritis whose condition did not improve … - Jul 20, 2005 At the time of presentation, she was being successfully treated with infliximab and methotrexate. During her pregnancy, the patient discontinued infliximab ... Nature.com … May Predict Clinical Response to Infliximab Treatment in Ankylosing... - Nov 11, 2006 Newswise — Infliximab, an antibody directed against tumor necrosis factor, has been shown to produce improvement in the signs and symptoms of ankylosing ... newswise.com Remicade (Infliximab) Appears Effective for Treatment of Psoriatic... - Feb 22, 2005 By Jerry Ingram. NEW ORLEANS, LA -- February 22, 2005 -- Remicade (infliximab) appears to significantly reduce the severity of two conditions associated ... DG News … to Eventual Clinical Response to Infliximab Treatment of Ankylosing... - Nov 16, 2006 Results show that infliximab significantly reduced IL-6 and VEGF levels within 2 weeks in ... [Presentation title: Comparison of the Effect of Infliximab on ... DG News … Treatment of Rheumatoid Arthritis with Infliximab and Methotrexate... - Nov 17, 2006 WASHINGTON, DC -- November 17, 2006 -- Early aggressive treatment with methotrexate and infliximab may lead to remission of rheumatoid arthritis, ... DG News Infliximab cuts ulcerative colitis colectomy rate.(Digestive Disorders... - Dec 1, 2007 PHILADELPHIA -- Patients with moderate to severe ulcerative colitis treated with infliximab had their colectomy rate cut by more than a third during the ... Free with registration - Family Practice News - AccessMyLibrary.com Infliximab effective for refractory sarcoidosis.(Clinical Rounds) |... - Jan 1, 2007 Infliximab effective for refractory sarcoidosis.(Clinical Rounds) ... find Skin & Allergy News articles. SALT LAKE CITY -- Infliximab is a highly effective ... Pay-Per-View - Skin & Allergy News - HighBeam Research Infliximab benefits lasting in plaque psoriasis: visible psoriasis... - Sep 1, 2005 GLASGOW, SCOTLAND -- In the first phase III trial evaluating infliximab for plaque psoriasis, substantial improvements were achieved by week 10 and ... Pay-Per-View - Family Practice News - Factiva, from Dow Jones Infliximab-induced headache and infliximab-induced meningitis: two... - May 1, 2005 Abstract: This report describes a case of aseptic meningitis induced by the tumor necrosis factor-[alpha] inhibitor infliximab. The patient, a 51-year-old ... $4.95 - Southern Medical Journal - ECNext Brand Names/Synonyms: Infliximab is also known by the following brand names and/or synonymsIg gamma-1 chain C region; Remicade (Centocor Inc) Drug Category: Infliximab is categorized under the following by the FDA: Immunomodulatory Agents; Immunosuppresants; unclassified therapeutic agents (92:00.00) Dosage Forms: POWDER FOR SOLUTION Absorption: Not Available Interactions: Not Available Chemical IUPAC Name: Chimeric mouse/human anti-TNF-alpha antibody (cA2) |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |